Drug Development Solutions

  1. A Scalable, Benchtop Mixing System For Sensitive Fluids 11/3/2025

    Examine a scalable, benchtop mixing system designed for sensitive fluids and GxP environments that supports automated control, traceability, and compliance from early development through production.

  2. Our Site Pfizer Ascoli: Oral Solid Dose 12/23/2025

    ASCOLI 2072 represents our long-term, forward-looking vision and our commitment to the sustainable future of our site. It guides how we think, how we act, and how we make decisions every day.

  3. Services For Advancing mRNA-LNPs From Bench To Clinic 2/27/2023

    Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

  4. ADCs: From Design To Development 1/4/2024

    Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.

  5. Plug Into The Future Of Bispecific Antibodies

    Lonza’s bYlok® technology is a true plug-and-play solution to bispecific antibody engineering – high product quality, simplified processes, unlocking the future.

  6. Multiparticulates For Modified Release Systems 1/12/2026

    Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.

  7. Co-Crystal Prediction Service 11/4/2025

    AI-driven co-crystal prediction accelerates solubility optimization by identifying ideal co-formers in days without needing the drug substance. Learn how to save time, reduce costs, and boost formulation success.

  8. Leveraging An Innovative Conjugation Technology For Better ADCs

    Learn how an advanced conjugation technology can provide a more uniform DAR profile, enhanced linker stability, and improved pharmacokinetic properties, paving the way for more efficacious ADCs.

  9. A Fully Integrated Toolbox For Therapeutic Protein Expression

    The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.

  10. Formulation Strategies For Poorly Soluble Molecules 10/15/2025

    As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.